Xconomy | Seattle - Business + Technology in the Exponential Economy

Related Posts

Biotech, Gene Therapy, Stewart Parker

Stewart Parker Resigns from Board of Targeted Genetics, Susan Robinson Takes Her Spot

Luke Timmerman 11/17/08

H. Stewart Parker has resigned from the board of Targeted Genetics, a week after she stepped down as president and CEO. The Seattle-based biotech company (NASDAQ: TGEN) named her replacement as CEO, Susan Robinson, to also fill Parker’s position on the board. Parker left the company she founded as a series of setbacks in the field of gene therapy put the company in a precarious position. Targeted Genetics stock closed Friday at 32 cents a share.

Luke Timmerman is the National Biotechnology Editor for Xconomy. You can e-mail him at ltimmerman@xconomy.com, call 206-624-2374, or follow him on Twitter at http://twitter.com/ldtimmerman.

Comments | Reprints | Share:   Retweet Facebook Email

Add Your Thoughts



You will have 10 minutes to edit your post after you press publish.

Comments may be edited for clarity and length, rejected, or deleted. By clicking "Publish," you are agreeing to these Terms and Conditions.

    
Xconomy network map Seattle Boston San Diego
national life-sciences startups

Most Popular Stories

Business, life sciences, and technology news — covering Boston, Seattle, San Diego, and beyond.

© 2007-2009, Xconomy, Inc. XCONOMY is a registered service mark of Xconomy, Inc. All rights reserved.
Site designed by Matthew Bouchard, produced by Andrew Koyfman, and powered by WordPress.